Thursday, September 5 12:30–1:45pm
P.A.C.T.: Practical Approaches to Comprehensive Treatment of Pain (Part 1)
Thursday, September 5 2–4:15pm
P.A.C.T.: Practical Approaches to Comprehensive Treatment of Pain (Part 2)
Thursday, September 5 7:30–8am
Test Your Knowledge: Labs & Imaging, Pulmonology, Rheumatology and More!
Thursday, September 5 10–11am
Alzheimer Disease in Primary Care: Early Identification and New Anti-Amyloid Treatment Options
Thursday, September 5 10–11am
Alzheimer Disease in Primary Care: Early Identification and New Anti-Amyloid Treatment Options
Thursday, September 5 12:30–1:45pm
P.A.C.T.: Practical Approaches to Comprehensive Treatment of Pain (Part 1)
Thursday, September 5 2–4:15pm
P.A.C.T.: Practical Approaches to Comprehensive Treatment of Pain (Part 2)
Thursday, September 5 8–9am
Two Sides of the Same Coin: A Dual-Focused Approach for Diabetes and Weight Management
Thursday, September 5 11–11:30am
Patient-Centered Clinical Care for African Americans: Cardiovascular Disease
Friday, September 6 1:30–2:30pm
Skin Deep: Mastering Benign and Malignant Conditions in Primary Care
Thursday, September 5 12:30–1:45pm
P.A.C.T.: Practical Approaches to Comprehensive Treatment of Pain (Part 1)
Thursday, September 5 2–4:15pm
P.A.C.T.: Practical Approaches to Comprehensive Treatment of Pain (Part 2)
Friday, September 6 10:15–11:15am
Multi-Cancer Early Detection: Overcoming Barriers to Cancer Screening
Thursday, September 5 4:30–6pm
Taking the Dialogue to the Next Level: Facilitating Open Communication About Obesity
Thursday, September 5 8–9am
Two Sides of the Same Coin: A Dual-Focused Approach for Diabetes and Weight Management
Thursday, September 5 4:30–6pm
Taking the Dialogue to the Next Level: Facilitating Open Communication About Obesity
Friday, September 6 7:30–8:15am
Friday, September 6 10:15–11:15am
Multi-Cancer Early Detection: Overcoming Barriers to Cancer Screening
Friday, September 6 8:15–9:15am
Aging Minds, Unique Challenges: Addressing Psychiatric Disorders in the Elderly Population
Disclosures
The following financial relationships have been disclosed by faculty, and all have been mitigated by Pri-Med Institute. Relevant relationships will be disclosed at the start of each presentation.
Financial Disclosures
- Charles E. Argoff, MD, FABPM
- Information to come
- Amy Clouse, MD, FAAFP
- Astellas Pharma, Advisor; Astellas Pharma, Speaker
- Anelyssa D'Abreu, MD, MPH, PhD
- No relevant financial relationships disclosed.
- Katherine E. Galluzzi, DO, CMD, FACOFP
- No relevant financial relationships disclosed.
- Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
- OptumRx, Consultant; Premier, Inc., Consultant
- Jennifer B. Green, MD
- Boehringer Ingelheim, Researcher; Lilly, Novo Nordisk, AstraZeneca, and Boehringer Ingelheim, Consultant
- Gregory L. Hall, MD
- No relevant financial relationships disclosed.
- Lawrence Herman, DMSc, MPA, PA-C, DFAAPA
- Novo Nordisk, Speaker
- Jonette Keri, MD, PhD
- Almirall, Advisor; L'Oreal, Advisor; Ortho Dermatologics, Advisor; Primus Pharmaceuticals, Advisor
- Gagan Mahajan, MD
- No relevant financial relationships disclosed.
- Mylynda B. Massart, MD, PhD
- GRAIL, LLC, Speaker
- Joynita R. R. Nicholson, DO, DABOM, FOMA
- No relevant financial relationships disclosed.
- Vani Potluri, MD
- No relevant financial relationships disclosed.
- Candace Westgate, DO, MPH, FACOG
- GRAIL and Myriad Genetics, Consultant; GRAIL and Myriad Genetics, Speaker
- Laila Woc-Colburn, MD
- No relevant financial relationships disclosed.
- Michael Ziffra, MD
- Information to come
Other Disclosures
Pamela Kushner, MD, FAAFP (Moderator, Reviewer): Speaker for Astellas, Bayer, and Corcept; Speaker & Advisor for AstraZeneca, GlaxoSmithKline, Janssen, Novo Nordisk, Lilly/BI, and Phathom; Speaker & Consultant for Haleon; Advisor for Abbott, Bausch/SALIX, Intuity, and Pfizer; Consultant for Abbott, AstraZeneca, Bayer, Boehringer Ingelheim, GlaxoSmithKline, and Lilly.
All other non-faculty contributors involved in the moderating, planning, development, editing and review of the content have disclosed no relevant financial relationships.